Canada markets open in 2 hours 18 minutes

  • S&P/TSX

    19,556.15
    -244.46 (-1.23%)
     

  • S&P 500

    4,273.53
    -63.91 (-1.47%)
     

  • DOW

    33,618.88
    -388.00 (-1.14%)
     

  • CAD/USD

    0.7390
    -0.0009 (-0.12%)
     

  • CRUDE OIL

    91.75
    +1.36 (+1.50%)
     

  • Bitcoin CAD

    35,811.79
    +316.34 (+0.89%)
     

  • CMC Crypto 200

    568.01
    +4.20 (+0.74%)
     

  • GOLD FUTURES

    1,911.60
    -8.20 (-0.43%)
     

  • RUSSELL 2000

    1,761.61
    -22.63 (-1.27%)
     

  • 10-Yr Bond

    4.5580
    0.0000 (0.00%)
     

  • NASDAQ futures

    14,762.50
    +47.50 (+0.32%)
     

  • VOLATILITY

    18.19
    -0.75 (-3.96%)
     

  • FTSE

    7,608.34
    -17.38 (-0.23%)
     

  • NIKKEI 225

    32,371.90
    +56.85 (+0.18%)
     

  • CAD/EUR

    0.6999
    +0.0005 (+0.07%)
     

Why Puma Biotechnology's Shares Jumped 20% on Monday

Jim Halley, The Motley Fool
·2 min read
Why Puma Biotechnology's Shares Jumped 20% on Monday

The biopharmaceutical company specializes in cancer therapies. Its stock got a boost on Monday when a Takeda Pharmaceutical (NYSE: TAK) candidate, ponatinib, hit its primary goal in a phase 3 clinical trial as a treatment for Philadelphia chromosome-positive acute lymphoblastic leukemia. The blood cancer therapy works by slowing the activity of BCR-ABL1, a gene sequence found in an abnormal chromosome 22, often seen in people with certain types of leukemia.

Continue reading